<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>7509229</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">32950903</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">7509229</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">S2213-1582(20)30268-0</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.1016/j.nicl.2020.102431</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">102431</article-id></all-ids><extracted-table><table-id>t0005</table-id><table-label>Table 1</table-label><table-caption>Demographic and clinical characteristics of all participants.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="t0005"><label>Table 1</label><caption><p>Demographic and clinical characteristics of all participants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>JME (n = 34)</th><th>HC (n = 34)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>Age (years)</td><td>17.38 ± 4.73</td><td>19.15 ± 3.46</td><td>0.21<sup>a</sup></td></tr><tr><td>Gender (males/females)</td><td>17/17</td><td>11/23</td><td>0.14<sup>b</sup></td></tr><tr><td>Handedness (right/left)</td><td>34/0</td><td>34/0</td><td>–</td></tr><tr><td>Seizure semiology</td><td>MS (34), GTCS (24)</td><td>–</td><td>–</td></tr><tr><td>Age at seizure onset (year)</td><td>15.29 ± 3.44</td><td>–</td><td>–</td></tr><tr><td>Duration of epilepsy (months)</td><td>23.76 ± 18.99</td><td>–</td><td>–</td></tr><tr><td>NHS3 total score</td><td>8.65 ± 3.92</td><td>–</td><td>–</td></tr><tr><td>Generalized convulsions</td><td>2.82 ± 1.85</td><td>–</td><td>–</td></tr><tr><td>Falls</td><td>1.50 ± 1.39</td><td>–</td><td>–</td></tr><tr><td>Incontinence</td><td>0.32 ± 0.81</td><td>–</td><td>–</td></tr><tr><td>Loss of consciousness</td><td>1.41 ± 0.82</td><td>–</td><td>–</td></tr><tr><td>Duration of recovery time</td><td>0.97 ± 0.67</td><td>–</td><td>–</td></tr><tr><td>Automatisms</td><td>0.68 ± 1.06</td><td>–</td><td>–</td></tr><tr><td>Mean FD</td><td>0.12 ± 0.05</td><td>0.11 ± 0.04</td><td>0.45<sup>a</sup></td></tr></tbody></table><table-wrap-foot><fn id="sp0050"><p><italic>Note</italic>: <sup>a</sup> two sample <italic>t</italic>-test, <sup>b</sup> chi-square <italic>t</italic> test; Values are mean ± SD.</p></fn><fn id="sp0055"><p>Abbreviations: MS, myoclonic seizure; GTCS, generalized tonic-clonic seizure; NHS3, national hospital seizure severity scale; FD, frame-wise displacement; JME, juvenile myoclonic epilepsy; HC, healthy control.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical characteristics of all participants.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th>JME (n = 34)</th><th>HC (n = 34)</th><th>P value</th></tr></thead><tbody><tr><td>Age (years)</td><td>17.38 ± 4.73</td><td>19.15 ± 3.46</td><td>0.21a</td></tr><tr><td>Gender (males/females)</td><td>17/17</td><td>11/23</td><td>0.14b</td></tr><tr><td>Handedness (right/left)</td><td>34/0</td><td>34/0</td><td>–</td></tr><tr><td>Seizure semiology</td><td>MS (34), GTCS (24)</td><td>–</td><td>–</td></tr><tr><td>Age at seizure onset (year)</td><td>15.29 ± 3.44</td><td>–</td><td>–</td></tr><tr><td>Duration of epilepsy (months)</td><td>23.76 ± 18.99</td><td>–</td><td>–</td></tr><tr><td>NHS3 total score</td><td>8.65 ± 3.92</td><td>–</td><td>–</td></tr><tr><td>Generalized convulsions</td><td>2.82 ± 1.85</td><td>–</td><td>–</td></tr><tr><td>Falls</td><td>1.50 ± 1.39</td><td>–</td><td>–</td></tr><tr><td>Incontinence</td><td>0.32 ± 0.81</td><td>–</td><td>–</td></tr><tr><td>Loss of consciousness</td><td>1.41 ± 0.82</td><td>–</td><td>–</td></tr><tr><td>Duration of recovery time</td><td>0.97 ± 0.67</td><td>–</td><td>–</td></tr><tr><td>Automatisms</td><td>0.68 ± 1.06</td><td>–</td><td>–</td></tr><tr><td>Mean FD</td><td>0.12 ± 0.05</td><td>0.11 ± 0.04</td><td>0.45a</td></tr></tbody></table></div>Note: a two sample t-test, b chi-square t test; Values are mean ± SD.Abbreviations: MS, myoclonic seizure; GTCS, generalized tonic-clonic seizure; NHS3, national hospital seizure severity scale; FD, frame-wise displacement; JME, juvenile myoclonic epilepsy; HC, healthy control.</transformed-table></extracted-table></extracted-tables-set>